MUMBAI, Sept 25 (Reuters) - The Indian rupees outlook remains weak and any rally in the currency fol
MUMBAI, Sept 25 (Reuters) - The Indian rupee dropped on Monday, losing momentum from JPMorgans inclu
BENGALURU, Sept 25 (Reuters) - The Burman family, which holds a controlling stake in Dabur (DABU.NS)
BENGALURU, Sept 25 (Reuters) - Shares of Indian casino operator Delta Corp (DELT.NS) plunged as much
MUMBAI, Sept 25 (Reuters) - The Indian rupee is likely to weaken on Monday as elevated U.S. Treasury
BENGALURU, Sept 25 (Reuters) - Indian shares are expected to start on a subdued note on Monday after
NEW DELHI, Sept 23 (Reuters) - Indias aviation authorities have ruled out intervening in a dispute between Akasa Air and its pilots after the budget carrier accused the regulator of inaction, a legal filing shows.
# trading range for the day is 82.92-83.26.# Rupee ended flat amid exporter dollar sales and fears o
Indian shares closed lower on Friday, with the benchmark Sensex logging its worst week in over 15 mo
NEW DELHI, Sept 22 (Reuters) - Rising oil prices are a concern for the Indian economy but its outloo
BENGALURU, Sept 22 (Reuters) - A fall in information technology and pharma stocks dragged Indias ben
SummaryCompaniesIndia to join benchmark GBI-EM index family in JuneEgypts eligibility in index serie
BENGALURU, Sept 22 (Reuters) - Indian benchmark indexes are expected to see a muted opening on Frida
SINGAPORE, Sept 22 (Reuters) - Hydropower generation in Asia has plunged at the fastest rate in deca
NEW DELHI, Sept 21 (Reuters) - Indian billionaire Mukesh Ambanis broadcasting unit Viacom18 is set t
NEW DELHI, Sept 21 (Reuters) - India is unlikely to export sugar in 2023-24 season as output will be
NEW DELHI, Sept 21 (Reuters) - Indian billionaire Mukesh Ambanis broadcasting unit Viacom18 is set t
BENGALURU, Sept 21 (Reuters) - Indias market regulator said on Thursday it will remove penalties on
Sept 21 (Reuters) - Glenmark Pharma (GLEN.NS) is offloading a majority of its stake in unit Glenmark Life Sciences (GLEM.NS) for 56.52 billion rupees ($679.84 million) as the Indian drugmaker looks to sharpen its focus on its key dermatology, oncology and respiratory therapies.
NEW DELHI, Sept 21 (Reuters) - Indian steel-to-energy group JSW is in early stage talks with Koreas